A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

Clinical trial NCT01674348 · TERMINATED

Trial details

NCT number: NCT01674348
Sponsor: Piramal Enterprises Limited
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2011-04-01
Primary completion: 2012-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.